Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Fresh woes emerge as Teva plunges to new lows - Globes
Teva misses on Q3 profit and revenue - Globes
Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Pharmaceutical Industries ADR (TEVA-N) Quote - The Globe and Mail
Teva reports heavy losses, sees minimal 2023 growth - Globes
Teva lied to evade accountability for role in New York's opioid crisis, state attorney-general says - The Globe and Mail
Teva targets sub-Saharan Africa - Globes
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva announces debt recycling measures - Globes
:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/tgam/IITRCH6KIBBTXLJ74B2DTSXL2M.jpg "U.S. to charge Teva with conspiring to raise prices of generic drugs, sources say - The Globe and Mail")
U.S. to charge Teva with conspiring to raise prices of generic drugs, sources say - The Globe and Mail
Teva expands sustainability notes issue to $5b - גלובס
Teva Pharmaceuticals - Wikipedia
Teva rejected opportunity to acquire Perrigo - גלובס
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Who We Are | Teva Pharmaceuticals
Teva boosted as FDA delays generic Copaxone - Globes
Israel sues Teva for $100m Copaxone royalties - Globes
Just 10% of Teva's employees located in Israel - Globes
Teva share price jumps 55% in past three weeks - Globes
Israeli drug giant Teva to move offices to Tel Aviv - Israel News - The Jerusalem Post
Teva to build new headquarters in Tel Aviv - Globes
/cloudfront-us-east-1.images.arcpublishing.com/tgam/L2ZF3OOC3ZIDBILQ4QEFIMK5GU.JPG "Teva Pharmaceutical to pay $523-million to New York State as it looks to move past opioid lawsuits - The Globe and Mail")
Teva Pharmaceutical to pay $523-million to New York State as it looks to move past opioid lawsuits - The Globe and Mail
Teva buys Allergan's generic drug business for $40.5bn | Pharmaceuticals industry | The Guardian
